Cardio Diagnostics Holdings (CDIO) Operating Margin (QoQ) (2023 - 2026)
Cardio Diagnostics Holdings (CDIO) Operating Margin (QoQ) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.88 Bn | 132.03 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.62 Bn | 78.62 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.28 Bn | 60.10 Bn | 1.37 Bn |
| 4 | Moderna | 61.39 Bn | 56.25 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.37 Bn | 28.06 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.76 Bn | 10.37 Bn | 668.28 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - |
| 10 | Cardio Diagnostics Holdings | 6.16 Mn | 568,998.29 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.86 Mn |
| Mar 31, 2026 | -2.54 Mn |
| Dec 31, 2025 | 1.88 Mn |
| Sep 30, 2025 | -3.75 Mn |
| Jun 30, 2025 | 15.10 Mn |
| Mar 31, 2025 | -13.99 Mn |
| Dec 31, 2024 | -1.22 Mn |
| Sep 30, 2024 | -511,732.00 |
| Jun 30, 2024 | 980,972.00 |
| Mar 31, 2024 | 293,424.00 |
| Dec 31, 2023 | -1.46 Mn |
| Sep 30, 2023 | 13.36 Mn |